WSC
LLY icon

Wellington Shields & Co’s Eli Lilly LLY Stock Holding History

Wellington Shields & Co’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.9M Sell
12,963
-14
-0.1% -$14.2K 3.04% 5
2025
Q4 		$13.9M Buy
12,977
+157
+1% +$150K 3.44% 4
2025
Q3 		$9.78M Buy
12,820
+55
+0.4% +$40.9K 2.55% 5
2025
Q2 		$9.95M Sell
12,765
-106
-0.8% -$82.4K 2.82% 5
2025
Q1 		$10.6M Sell
12,871
-364
-3% -$303K 3.33% 4
2024
Q4 		$10.2M Sell
13,235
-300
-2% -$248K 3.13% 4
2024
Q3 		$12M Sell
13,535
-1
-0% -$899 3.65% 3
2024
Q2 		$12.3M Sell
13,536
-196
-1% -$157K 3.99% 3
2024
Q1 		$10.7M Buy
13,732
+120
+0.9% +$85.4K 3.58% 3
2023
Q4 		$7.93M Buy
13,612
+423
+3% +$247K 2.93% 4
2023
Q3 		$7.08M Sell
13,189
-671
-5% -$346K 1.77% 4
2023
Q2 		$6.5M Buy
13,860
+61
+0.4% +$25.6K 1.53% 6
2023
Q1 		$4.74M Buy
13,799
+12
+0.1% +$4.05K 1.06% 8
2022
Q4 		$5.04M Buy
13,787
+83
+0.6% +$29.4K 1.15% 8
2022
Q3 		$4.43M Sell
13,704
-740
-5% -$234K 1.93% 8
2022
Q2 		$4.68M Sell
14,444
-1,389
-9% -$417K 1.13% 7
2022
Q1 		$4.53M Buy
15,833
+12
+0.1% +$3.09K 1.49% 11
2021
Q4 		$4.37M Buy
15,821
+12
+0.1% +$3.04K 0.87% 14
2021
Q3 		$3.65M Sell
15,809
-189
-1% -$46.6K 1.27% 13
2021
Q2 		$3.67M Buy
15,998
+12
+0.1% +$2.41K 1.21% 14
2021
Q1 		$2.99M Sell
15,986
-1,487
-9% -$291K 1.07% 23
2020
Q4 		$2.95M Sell
17,473
-85
-0.5% -$12.7K 1.06% 21
2020
Q3 		$2.6M Buy
17,558
+16
+0.1% +$2.48K 1.09% 25
2020
Q2 		$2.88M Sell
17,542
-84
-0.5% -$12.9K 1.26% 21
2020
Q1 		$2.44M Buy
17,626
+17
+0.1% +$2.34K 1.35% 17
2019
Q4 		$2.31M Buy
+17,609
New +$2.04M 1.03% 23
2019
Q3 		– Sell
-17,574
Closed -$1.95M – 159
2019
Q2 		$1.95M Buy
17,574
+167
+1% +$19.7K 0.92% 29
2019
Q1 		$2.26M Buy
17,407
+16
+0.1% +$1.95K 1.15% 20
2018
Q4 		$2.01M Buy
17,391
+13,515
+349% +$1.51M 1.15% 20
2018
Q3 		$416K Buy
3,876
+16
+0.4% +$1.6K 0.23% 92
2018
Q2 		$329K Buy
3,860
+20
+0.5% +$1.64K 0.17% 106
2018
Q1 		$297K Buy
3,840
+22
+0.6% +$1.77K 0.16% 113
2017
Q4 		$322K Buy
3,818
+18
+0.5% +$1.53K 0.17% 110
2017
Q3 		$325K Hold
3,800
– – 0.11% 102
2017
Q2 		$313K Hold
3,800
– – 0.11% 97
2017
Q1 		$320K Hold
3,800
– – 0.1% 94
2016
Q4 		$279K Sell
3,800
-1,800
-32% -$134K 0.15% 98
2016
Q3 		$449K Sell
5,600
-300
-5% -$24K 0.23% 63
2016
Q2 		$465K Hold
5,900
– – 0.29% 58
2016
Q1 		$425K Hold
5,900
– – 0.28% 54
2015
Q4 		$497K Buy
5,900
+300
+5% +$24.9K 0.33% 51
2015
Q3 		$469K Hold
5,600
– – 0.35% 53
2015
Q2 		$468K Hold
5,600
– – 0.16% 56
2015
Q1 		$407K Hold
5,600
– – 0.24% 63
2014
Q4 		$386K Buy
5,600
+800
+17% +$54K 0.22% 68
2014
Q3 		$311K Buy
+4,800
New +$304K 0.2% 79
2013
Q3 		– Sell
-6,700
Closed -$329 – 116
2013
Q2 		$329 Buy
+6,700
New +$365K 0.01% 87

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Shields & Co's LLY Position: Q1 2026 in Review

Wellington Shields & Co reduced its Eli Lilly (LLY) stake by 0.11% in Q1 2026, selling an estimated $14.2K and leaving 12,963 shares worth $11.9M. The position accounts for 3.04% of the portfolio, ranked #5.

Wellington Shields & Co first reported a position in LLY in Q2 2013 and has held it in 47 quarters since. The position peaked at $13.9M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Wellington Shields & Co held 12,963 shares of Eli Lilly worth $11.9M as of Q1 2026.
  • Wellington Shields & Co sold 14 Eli Lilly shares in Q1 2026, an estimated $14.2K.
  • Eli Lilly made up 3.04% of Wellington Shields & Co's portfolio in Q1 2026, its #5 holding.
  • Wellington Shields & Co first reported a position in Eli Lilly in Q2 2013 and has held it in 47 quarters since.
  • Wellington Shields & Co's Eli Lilly position peaked at $13.9M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Wellington Shields & Co's 13F filing for Q1 2026, filed 4 May 2026.